Skip to main content
Clinical Trials/CTRI/2023/08/057143
CTRI/2023/08/057143
Active, Not Recruiting
Phase 3

Comparative evaluation of Platelet Rich Fibrin (PRF) and Titanium-Platelet Rich Fibrin (T-PRF) in the Treatment of Intrabony defects using 1% Metformin gel - A Clinical Study. - NI

Raaja Sreepathy CS0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
Raaja Sreepathy CS
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Raaja Sreepathy CS

Eligibility Criteria

Inclusion Criteria

  • 1\.Apparently healthy individuals.
  • 2\. Presence of Intrabony defect (IBD) depth \=3 mm and interproximal probing depth (PD) \=5 mm after phase I therapy.

Exclusion Criteria

  • 1\. HISTORY OF :
  • Aggressive Periodontitis. Smoking and tobacco use. Systemic conditions known to affect the periodontal status. Medications known to affect the gingival condition
  • 2\. Pregnant or lactating women.
  • 3\. Hematological disorders and insufficient platelet count after re\-evaluation of Phase I therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials